Tenaya Therapeutics, Inc.
Data quality: 83%
TNYA
Nasdaq
Manufacturing
Chemicals
$0.74
▲
$0.02
(2.14%)
Mkt Cap: 160.71 M
Price
$0.74
Mkt Cap
160.71 M
Day Range
$0.71 — $0.78
52-Week Range
$0.36 — $2.35
Volume
3,278,957
Open $0.72
50D / 200D Avg
$0.73
1.13% above
50D / 200D Avg
$1.02
27.22% below
Quick Summary
Key Takeaways
Negative free cash flow of -68.88 M
Growth
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Quality
Return on Equity
-99.18%
Below sector avg (-53.41%)
ROIC-73.27%
Net MarginN/A
Op. MarginN/A
Safety
Debt / Equity
N/A
Current Ratio4.64
Interest CoverageN/A
Valuation
PE (TTM)
-1.77
Below sector avg (-1.48)
P/B Ratio1.94
EV/EBITDAN/A
Dividend YieldN/A
Price History
Financial Trends
Peer Comparison
vs Manufacturing sector median (1364 peers)
Peer Comparison
vs Manufacturing sector median (1364 peers)| Metric | Stock | Sector Median |
|---|---|---|
| P/E | -1.8 | -1.5 |
| P/B | 1.9 | 1.6 |
| ROE % | -99.2 | -53.4 |
| Net Margin % | — | -41.5 |
| Rev Growth 5Y % | — | 1.8 |
| D/E | — | 0.3 |
All Fundamental Metrics
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | N/A | Net Income (TTM) | -90.60 M |
| ROE | -99.18% | ROA | -79.78% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | -68.88 M |
| ROIC | -73.27% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | N/A | Current Ratio | 4.64 |
| Interest Coverage | N/A | Asset Turnover | N/A |
| Working Capital | 48.03 M | Tangible Book Value | 82.87 M |
| Dividends | |||
| Dividend Yield | N/A | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -1.77 | Forward P/E | N/A |
| P/B Ratio | 1.94 | P/S Ratio | N/A |
| PEG Ratio | N/A | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | -42.86% | ||
| Market Cap | 160.71 M | Enterprise Value | 104.40 M |
| Per Share | |||
| EPS (Diluted TTM) | -0.59 | Revenue / Share | N/A |
| FCF / Share | -0.32 | OCF / Share | -0.31 |
| EPS CAGR (1Y) | N/A | EPS CAGR (5Y) | N/A |
| EPS CAGR (10Y) | N/A | ||
| Efficiency | |||
| CapEx / Revenue | N/A | FCF Conversion | 76.03% |
| SBC-Adj. FCF | -83.09 M | Growth Momentum | N/A |
Income Statement
Annual, most recent first
Income Statement
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | — | — | — | — | — |
| Net Income | -90.60 M | -111.13 M | -124.08 M | -123.67 M | -72.72 M |
| EPS (Diluted) | -0.59 | -1.31 | -1.68 | -2.76 | — |
| Gross Profit | — | — | — | — | — |
| Operating Income | -93.33 M | -115.95 M | -131.19 M | -125.62 M | -72.81 M |
| EBITDA | — | — | — | — | — |
| R&D Expenses | 68.61 M | 86.74 M | 98.04 M | 94.54 M | 54.39 M |
| SG&A Expenses | — | — | — | — | — |
| D&A | 8.44 M | 8.47 M | 8.69 M | 6.47 M | 2.96 M |
| Interest Expense | — | — | — | — | — |
| Income Tax | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Balance Sheet
Annual, most recent first
Balance Sheet
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 146.92 M | 119.94 M | 170.52 M | 278.95 M | 314.19 M |
| Total Liabilities | 23.66 M | 27.09 M | 31.09 M | 35.57 M | 35.66 M |
| Shareholders' Equity | 123.27 M | 92.85 M | 139.42 M | 243.38 M | 278.53 M |
| Total Debt | — | — | — | — | — |
| Cash & Equivalents | 100.55 M | 4.32 M | 45.68 M | 95.27 M | 38.13 M |
| Current Assets | 105.59 M | 67.38 M | 111.58 M | 193.75 M | 255.36 M |
| Current Liabilities | 15.44 M | 15.98 M | 22.73 M | 24.25 M | 21.77 M |
{"event":"ticker_viewed","properties":{"ticker":"TNYA","listing_kind":"stock","pathname":"/stocks/tnya","exchange":"Nasdaq","country":"US"}}